Metabolism studies
Preclinical studies:
- Dose-finding studies
- Toxicological studies
- Pharmacokinetic studies
- Toxicokinetic studies
- ADME or ADME-Tox studies
- DMPK studies
Clinical trials (phases 0-III)
Metabolism studies
Preclinical studies:
Clinical trials (phases 0-III)
Bioequivalence/bioavailability studies
Biomarker development and validation
Biomarker studies
Stability studies
Enzyme activity studies
Biosimilar studies
Pharmacokinetic issues
© 2017 Prolytic GmbH